Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001705023 | SCV000241687 | likely benign | not provided | 2020-12-29 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000645274 | SCV000767016 | benign | Intellectual disability, autosomal dominant 1 | 2024-01-18 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002317120 | SCV000850266 | likely benign | Inborn genetic diseases | 2023-06-21 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV001705023 | SCV004154071 | likely benign | not provided | 2023-08-01 | criteria provided, single submitter | clinical testing | MBD5: BP4 |
Breakthrough Genomics, |
RCV001705023 | SCV005255797 | likely benign | not provided | criteria provided, single submitter | not provided |